Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319689296
Publisher: Springer International Publishing Publication: November 25, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319689296
Publisher: Springer International Publishing
Publication: November 25, 2017
Imprint: Springer
Language: English

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

More books from Springer International Publishing

Cover of the book Digital Storage in Consumer Electronics by
Cover of the book Modern Sensing Technologies by
Cover of the book Campaign Professionalism during Egypt’s 2012 Presidential Election by
Cover of the book Regulating Corporate Criminal Liability by
Cover of the book Ocean Science and the British Cold War State by
Cover of the book MEMS Lorentz Force Magnetometers by
Cover of the book Stereotypes and Self-Representations of Women with a Muslim Background by
Cover of the book Illustrating Finance Policy with Mathematica by
Cover of the book Gondwana Industrial Clays by
Cover of the book Evolution of Motions of a Rigid Body About its Center of Mass by
Cover of the book Cardiovascular Complications in Cancer Therapy by
Cover of the book Mathematics in Everyday Life by
Cover of the book Nonlinearly Perturbed Semi-Markov Processes by
Cover of the book Postcolonialism and Postsocialism in Fiction and Art by
Cover of the book WALCOM: Algorithms and Computation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy